Cardiovascular Risk Profile of Antirheumatic Agents in Patients with Osteoarthritis and Rheumatoid Arthritis

被引：0
|
作者：
Michael T. Nurmohamed
Vokko P. van Halm
Ben A. C. Dijkmans
机构：
[1] VU University Medical Centre,Department of Rheumatology
[2] Jan van Breemen Institute,undefined
[3] Slotervaart Hospital,undefined
来源：
Drugs | 2002年 / 62卷
关键词：
Rheumatoid Arthritis; Infliximab; Etanercept; Celecoxib; Naproxen;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Several new drugs have become available for the treatment of patients with osteoarthritis and rheumatoid arthritis (RA). These agents include selective cyclooxygenase (COX)-2 inhibitors, leflunomide and anti-tumour necrosis factor (TNF)-α antagonists.
引用
收藏
页码：1599 / 1609
页数：10
相关论文
共 50 条
  • [21] Effect Of Biologic Agents On Lipids and Cardiovascular Risk In Rheumatoid Arthritis Patients.
    Pappas, Dimitrios A.
    John, Ani
    Curtis, Jeffrey R.
    Reed, George W.
    Greenberg, Jeffrey D.
    Shewade, Ashwini
    Solomon, Daniel H.
    Kremer, Joel M.
    Sommers, Tanya
    ARTHRITIS AND RHEUMATISM, 2013, 65 : S1210 - S1211
  • [22] Effect of Biologic Agents on Lipid Levels and Cardiovascular Risk in Rheumatoid Arthritis Patients
    Pappas, Dimitrios
    Giles, Jon
    Reed, George
    Kane, Kevin
    Curtis, Jeffrey
    Kremer, Joel
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 1780 - 1782
  • [23] The Risk of Cardiovascular Events Associated With Disease-modifying Antirheumatic Drugs in Rheumatoid Arthritis
    Ozen, Gulsen
    Pedro, Sofia
    Michaud, Kaleb
    JOURNAL OF RHEUMATOLOGY, 2021, 48 (05) : 648 - 655
  • [24] LIPID PROFILE AND CARDIOVASCULAR RISK IN SUBJECTS AT RISK FOR DEVELOPING RHEUMATOID ARTHRITIS
    van Boheemen, L.
    van Beers-Tas, M.
    van Schaardenburg, D.
    Nurmohamed, M. T.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 280 - 280
  • [25] Inflammation, Disease-Modifying Antirheumatic Drugs, Lipids, and Cardiovascular Risk in Rheumatoid Arthritis
    Liao, Katherine P.
    Solomon, Daniel H.
    ARTHRITIS & RHEUMATOLOGY, 2015, 67 (02) : 327 - 329
  • [26] Prescribing Trend of Antirheumatic Drugs in Taiwan and Risk of Cardiovascular Disease in Patients with Rheumatoid Arthritis: A Nationwide Cohort Study
    Lee, Chien-Ying
    Tai, Chih-Jaan
    Tsai, Ya-Fang
    Kuan, Yu-Hsiang
    Lee, Chiu-Hsiang
    Huang, Kuang-Hua
    BIOMED RESEARCH INTERNATIONAL, 2019, 2019
  • [27] PREDICTING CARDIOVASCULAR RISK IN PATIENTS WITH RHEUMATOID ARTHRITIS
    Agca, R.
    van Sijl, A. M.
    Voskuyl, A. E.
    Nurmohamed, M. T.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 684 - 685
  • [28] CARDIOVASCULAR RISK STRATIFICATION IN PATIENTS WITH RHEUMATOID ARTHRITIS
    Pusineri, P.
    Cabrera-Villalba, S.
    Avila, G.
    Leiva, E.
    Valinotti, V.
    Roman, L.
    Pineda, A.
    Acosta-Colman, I.
    Martinez, M.
    Trigueros, P. De Abreu
    Centurion, O.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1338 - 1339
  • [29] Assessment of Cardiovascular Risk in Patients with Rheumatoid Arthritis
    Matteson, Eric L.
    Mankad, Rekha
    JOURNAL OF RHEUMATOLOGY, 2016, 43 (11) : 1947 - 1949
  • [30] CARDIOVASCULAR RISK IN PATIENTS WITH ESTABLISHED RHEUMATOID ARTHRITIS
    Pineda, G.
    Valinotti, V.
    Roman, L.
    Acosta, R.
    Riquelme, S.
    Coronel, J.
    Avila, G.
    Acosta-Colman, I.
    Martinez, M.
    Centurion, O.
    Cabrera-Villalba, S.
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2020, 26 : 141 - 142
12345